Nerivio® Drug-free Wearable Surpasses 100,000 Migraine Treatments in the US
Similar Posts
Strive Health Selects Bamboo Health to Optimize Care Coordination for Improved Patient Outcomes
Leader in value-based kidney care to utilize admission, discharge and transfer data from Pings and Spotlights solutions for real-time…
Clearlake Capital-Backed nThrive Announces Name Change to FinThrive as Part of a Forthcoming Rebrand
New Company vision challenges the traditional approach from legacy incumbent solutions to revenue cycle management software and technology…
100Plus Enables Sweetwater Medical Associates to Improve Patient Adherence and Health Metrics with AI-Assisted Remote Patient Monitoring
RPM solution helps monitor, measure and support at-risk populations in their homes to improve access to care, drive better…
FDA Approves Theranica’s Nerivio® for Acute Treatment of Migraine in Adolescents
The Prescribed Wearable Device is Now indicated for Patients 12 Years Old and Above Theranica, a prescribed digital therapeutics (PDT)…
